US2019169255A1PendingUtilityA1

Il-2 muteins and uses thereof

74
Assignee: PANDION THERAPEUTICS INCPriority: Dec 6, 2017Filed: Dec 21, 2018Published: Jun 6, 2019
Est. expiryDec 6, 2037(~11.4 yrs left)· nominal 20-yr term from priority
Inventors:Nathan Higginson-ScottJoanne L. VineyJyothsna VisweswaraiahErik Robert SampsonKevin Lewis Otipoby
A61K 38/00C07K 2319/30C07K 14/55
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A protein consisting of an amino acid sequence of SEQ ID NO: 39. 
     
     
         2 . A pharmaceutical composition comprising a protein of  claim 1  and a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2019169255A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.